It is known that approximately 10–15% of ovarian cancer patients harbor a germline mutation in genes encoding BRCA1 and BRCA2 proteins, which are involved in the process of homologous recombination (HR) that mediates repair of double stranded DNA breaks [58]. The gene discussed is BRCA2; the disease is ovarian carcinoma.